|
Status |
Public on Jan 12, 2023 |
Title |
Superenhancer-driven lncRNA FASRL in hepatocellular carcinoma [RNA-seq] |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Superenhancers drive abnormal gene expression in tumors and promote malignancy. However, the relationship between superenhancer-associated lncRNA and abnormal metabolism is unknown.
|
|
|
Overall design |
In this work, we aimed to investigate the specific mechanism by which superenhancer-related lncRNAs function in lipid metabolism in hepatocellular carcinoma.
|
|
|
Contributor(s) |
Peng L |
Citation(s) |
36307901 |
|
Submission date |
Jun 21, 2022 |
Last update date |
Jan 12, 2023 |
Contact name |
Li Peng |
E-mail(s) |
pengli9@mail.sysu.edu.cn
|
Phone |
+86 20 81332402
|
Organization name |
Sun Yat-Sen Memorial Hospital
|
Street address |
No. 107 Yanjiang West Road
|
City |
Guangzhou |
ZIP/Postal code |
510120 |
Country |
China |
|
|
Platforms (1) |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE206549 |
Superenhancer-driven lncRNA FASRL in hepatocellular carcinoma |
|
Relations |
BioProject |
PRJNA851364 |